1.Progress of anti-tumor mechanisms of statins
Yong ZHANG ; Yaqian QIN ; Duo YIN
Cancer Research and Clinic 2018;30(10):710-713
Statins are a kind of hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors, which are commonly used to reduce cholesterol level, and prevent cardiovascular and cerebrovascular diseases. In recent years, more and more researches have showed that statins could inhibit angiogenesis through inhibiting the proliferation, invasion and metastasis of cancer cells, and could promote cancer cells apoptosis and synergetically enhance the effect of radiotherapy and chemotherapy to play a potential anti-tumor role. This paper reviews the domestic and foreign research progresses of the anti-tumor mechanisms of statins.
2. Progress of Research on Relationship Between Intestinal Flora, Immunity and Gallstone
Yaqian NING ; Huili WANG ; Dangdang YANG ; Shan LIN ; Bing HU ; Yaqian NING ; Wenhao QIN ; Huili WANG ; Dangdang YANG ; Shan LIN ; Bing HU
Chinese Journal of Gastroenterology 2023;28(5):302-306
Gallstone disease is a common and frequently seen disease of digestive system, and is a common cause of inflammation of gallbladder and bile duct, biliary tract tumor and obstructive jaundice, however, its pathogenesis is not yet fully understood. Recent studies have revealed that intestinal flora and immunity play important roles in the formation of gallstones. This paper reviewed the relationship between the abundance and composition of intestinal flora, immuno - globulins, mucins and immune cells, as well as the interactions between intestinal flora and biliary immunity and gallstone formation for providing new ideas and methods for gallstone prevention and treatment.
3.Preventive and therapeutic effects of berberine on liver diseases and its mechanism
Huili WANG ; Wenhao QIN ; Dangdang YANG ; Yaqian NING ; Shan LIN ; Songlin DAI ; Bing HU
Journal of Clinical Hepatology 2024;40(11):2326-2331
Berberine is an antipyretic and detoxicating drug commonly used in clinical practice,and it is currently used for the routine treatment of gastrointestinal diseases such as bacterial gastroenteritis and diarrhea.However,several recent studies have shown that berberine can exert a therapeutic effect on the diseases such as autoimmune hepatitis,viral hepatitis,nonalcoholic fatty liver disease,and liver cancer by regulating the AMPK and TGF-β pathways and altering the composition of intestinal flora.This provides new drugs for the treatment of these diseases,expands the potential indications of berberine,and provides clues for the follow-up research and development of similar drugs.This article summarizes the therapeutic effect and mechanism of berberine on various liver diseases,in order to provide a reference for effective clinical application.